Le Xu

36 total papers · 557 total citations
26 papers, 428 citations indexed

About

Le Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Le Xu has authored 26 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Le Xu's work include Renal cell carcinoma treatment (4 papers), Cancer-related gene regulation (4 papers) and Hedgehog Signaling Pathway Studies (2 papers). Le Xu is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Cancer-related gene regulation (4 papers) and Hedgehog Signaling Pathway Studies (2 papers). Le Xu collaborates with scholars based in China and United States. Le Xu's co-authors include Chen Zhao, Ming Lü, Jiejie Xu, Haiou Liu, Weisi Liu, Qiang Fu, Deng Pan, Weijuan Zhang, Wenbin Wang and Qingxiang Li and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Medicine.

In The Last Decade

Le Xu

26 papers receiving 421 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Le Xu 261 116 82 59 49 26 428
George Baltatzis 266 1.0× 134 1.2× 69 0.8× 70 1.2× 60 1.2× 23 437
Malay Choudhury 189 0.7× 44 0.4× 45 0.5× 128 2.2× 66 1.3× 22 471
Joseph D. Coppock 135 0.5× 86 0.7× 69 0.8× 38 0.6× 38 0.8× 24 391
Yun Ma 324 1.2× 165 1.4× 65 0.8× 28 0.5× 24 0.5× 36 470
Kaori Nagao 277 1.1× 62 0.5× 37 0.5× 27 0.5× 40 0.8× 14 477
Xuan Zhang 192 0.7× 38 0.3× 37 0.5× 17 0.3× 47 1.0× 23 374
Jia Wei 214 0.8× 133 1.1× 111 1.4× 73 1.2× 78 1.6× 33 429
Mahendra Pal Singh 120 0.5× 56 0.5× 86 1.0× 29 0.5× 104 2.1× 36 402
Yang Deng 186 0.7× 128 1.1× 72 0.9× 17 0.3× 55 1.1× 24 434
Eszter Csánky 267 1.0× 106 0.9× 44 0.5× 82 1.4× 86 1.8× 29 457

Countries citing papers authored by Le Xu

Since Specialization
Citations

This map shows the geographic impact of Le Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Xu more than expected).

Fields of papers citing papers by Le Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Xu. The network helps show where Le Xu may publish in the future.

Co-authorship network of co-authors of Le Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Le Xu. A scholar is included among the top collaborators of Le Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le Xu. Le Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026